The Choice of Eating Cicadas or Supporting Local Farms:
I swear I read an article, not even tongue-in-cheek on ZeroHedge (perhaps outside the search range I use or they pulled it; yes, in history, it is now “404” meaning dead) discussing the merits of eating the bugs. In any event, other sites discussed the topic of “Brood X” as a food source, very much a dream of the oligagarchs at the World Economic Forum. If you don’t have to own anything to be happy, you’ll be very happy eating free bugs.
WikiMedia Commons:
. Rock Creek Park, Washington, DC, USA.+
Bernardo Kordon, casi veinte años de silencio pagina12.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pagina12.com.ar Daily Mail and Mail on Sunday newspapers.
“The process is so convoluted, you need to streamline it,” said Bernstein.
“She lives by herself, she has no TV, she has no internet. Limited phone access,” said Aida Nunez of Manchester, who struggled all day to help her 85-year-old friend from Hartford sign up.
She said her friend has no family to help her.
And even someone as tech savvy as her can’t figure it out.
“All of these numbers say busy, busy, busy or you go to this website and how can I go to this website and if I don’t know how, Ms. Johnson sure don’t know how.”
by Barry Teater, NCBiotech writer January 6, 2021 .
RESEARCH TRIANGLE PARK – Raleigh-based Marius Pharmaceuticals, led by several former GlaxoSmithKline scientists and executives, is making progress on its first potential drug.
Marius has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of Kyzatrex, its novel treatment for hypogonadism, or testosterone deficiency, in men.
“Submission of our first NDA is an important milestone, bringing attention to the role of testosterone as a critical hormone and the multitude of effects it can have on our health system,” said
Himanshu H. Shah (Marius photo)
, founder and executive chairman of Marius, in a prepared statement. “This is the culmination of over a decade of meticulous research and dedication and is just the beginning for Marius, as our deep pipeline will continue to further the research and development in this important therapeutic area.”